About our promoted products: Our 'promoted' products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you. Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment
|52-week range||USD$2.78 - USD$24.5|
|50-day moving average||USD$17.8143|
|200-day moving average||USD$11.2828|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.299|
|1 week (2021-04-13)||-11.52%|
|1 month (2021-03-19)||-32.06%|
|3 months (2021-01-21)||3.63%|
|6 months (2020-10-21)||180.77%|
|1 year (2020-04-21)||299.39%|
|2 years (2019-04-18)||71.76%|
|3 years (2018-04-20)||57.93%|
|5 years (2016-04-21)||885.75%|
Valuing Aphria stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aphria's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aphria's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Aphria shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Aphria's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$9 million.
The EBITDA is a measure of a Aphria's overall financial performance and is widely used to measure a its profitability.
There are currently 16.0 million Aphria shares held short by investors – that's known as Aphria's "short interest". This figure is 12% up from 14.3 million last month.
There are a few different ways that this level of interest in shorting Aphria shares can be evaluated.
Aphria's "short interest ratio" (SIR) is the quantity of Aphria shares currently shorted divided by the average quantity of Aphria shares traded daily (recently around 16.6 million). Aphria's SIR currently stands at 0.96. In other words for every 100,000 Aphria shares traded daily on the market, roughly 960 shares are currently held short.
However Aphria's short interest can also be evaluated against the total number of Aphria shares, or, against the total number of tradable Aphria shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aphria's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Aphria shares in existence, roughly 50 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Aphria shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aphria.
What to consider before you invest in biotechnology companies.
Steps to owning and managing SOS shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Arrival shares, with 24-hour and historical pricing before you buy.
Step-by-step instructions to help you invest in Briscoe Group shares on New Zealand’s Exchange.
Your simple, step-by-step guide on how to buy TLT shares on the NZX.
Step-by-step instructions on how to buy Comvita shares on the NZX.
Steps to owning and managing Vector Acquisition Corp shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Rocket Companies shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing EHang shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Tilray shares, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.